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"STRIKING OUT": THE GENETIC INFORMATION
NONDISCRIMINATION ACT OF 2008 AND TITLE II'S IMPACT ON
PROFESSIONAL SPORTS EMPLOYERS
Rhonda B. Evans'
The Genetic Information Nondiscrimination Act ("GINA') is a
recently enacted law that prohibits employers and insurance
companies from discriminating against people based upon their
genetic information. Soon after the passage of GINA, many people
praised the law, but the flaws of GINA have not been as widely
talked about. This Recent Development addresses a major flaw in
GINA, the lack of a "direct threat" exception such as there is in
the Americans with Disabilities Act. GINA is discussed in the
context of professional sports, where the imperfections in GINA
are most evident.
I. INTRODUCTION
Lou Gehrig is an American baseball hero.2 He will always be
remembered for the World Series Championships he helped the
Yankees win,' his fierce competition with legendary players Babe
Ruth and Joe DiMaggio, and his famous speech in Yankee
' J.D. Candidate, University of North Carolina School of Law, 2011.
2 Lou Gehrig: The Official Website, Biography, 1-5, http://www.lougehrig.
com/about/bio.htm (last visited Dec. 3, 2009) (on file with the North Carolina
Journal of Law & Technology). Lou Gehrig was born in New York City in
1903. He played for the New York Yankees from 1925 to 1938. He played
2,130 straight games for the Yankees and has "the 15th all time highest" lifetime
batting average. Id.
3 Id. Gehrig helped the Yankees win six World Series titles. Id.
4 Id. at 2, 3 ("Ruth and Gehrig began to dominate the baseball headlines in
1927 in a way two players had never done before. That year Ruth hit 60
homers, breaking his old record of 59, and Gehrig clouted 47, more than anyone
other than Ruth had ever hit. As late as August 10th, Gehrig had more homers
than the Babe, but Ruth's closing kick was spectacular. Together they out-
homered every team in baseball except one.... DiMaggio and Gehrig would
dominate the league the way Gehrig and Ruth had, and the Yankees began a
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Stadium on July 4, 1939, when he declared that he was "the
luckiest man on the face of the earth."' Perhaps Lou Gehrig will
be more commonly remembered for the reason he chose to retire
from the Yankees 6-his diagnosis with a genetic degenerative
disease called amyotrophic lateral sclerosis ("ALS"), or more
widely known as Lou Gehrig's disease.' Genetic testing was not
available when Gehrig was diagnosed with ALS in 1939.'
However, if genetic tests were available and utilized by the
Yankees, would Gehrig's increased potential for developing ALS,
a disease that seriously impairs one's motor skills,' have negatively
impacted his future with the team? While it is impossible to know
the answer to this question, there is a strong possibility that Gehrig
would have been subject to genetic tests due to an increase in the
use of genetic testing by professional sports organizations."o
four-season dynasty that included winning four World Series and losing only
three games out of 19. In 1936, Gehrig led the league in home runs and runs
scored. The next year DiMaggio did the same.").
5 Id. at 5 ("New York sportswriter Paul Gallico suggested the team have a
recognition day to honor Gehrig on July 4, 1939. There were more than 62,000
fans in attendance as Gehrig stood on the field at Yankee Stadium with the 1927
and 1939 Yankees. He fought back tears of overwhelming emotion and began
to speak his immortal words of thanks, calling himself 'the luckiest man on the
face of the earth.' It was one of the most poignant and emotional moments in the
history of American sports, and there was not a dry eye in Yankee Stadium.").
6 Id. at 4 (Gehrig retired in the middle of the season in 1939 after being
diagnosed at the Mayo Clinic with ALS).
7 Id. ("ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's
Disease, is an incurable fatal neuromuscular disease characterized by
progressive muscle weakness, resulting in paralysis. The disease attacks nerve
cells in the brain and spinal cord. Motor neurons, which control the movement
of voluntary muscles, deteriorate and eventually die. When the motor neurons
die, the brain can no longer initiate and control muscle movement. Because
muscles no longer receive the messages they need in order to function, they
gradually weaken and deteriorate.").
8 Robert Wright, James Watson & Francis Crick, TIME, Mar. 29, 1999, at 172
(DNA (deoxyribonucleic acid) was not discovered until the 1950's by two
scientists, James Watson & Francis Crick).
9 See supra note 7 and accompanying text.
1o See generally Michael S. Schmidt & Alan Schwarz, Baseball's Use of DNA
Raises Questions, N.Y. TIMES, July 22, 2009 at Al. (discussing Major League
Baseball's use of genetic tests on potential players).
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The increasing availability of genetic testing," coupled with
lowering costs of genetic tests,12 has led to an increase in the use of
testing on players by professional sports organizations for various
reasons. 3  Genetic testing has brought about an intense debate
about the ethical and legal implications of employers using genetic
tests within professional sports (and employers in general). 4
However, genetic testing on professional sports players may
become increasingly more difficult with the passage of the Genetic
Information Nondiscrimination Act of 2008 (GINA) and
specifically Title II." GINA 6 is "[a]n Act [t]o prohibit
discrimination on the basis of genetic information with respect to
health insurance and employment."" Title II directly addresses
employment discrimination and states that:
It shall be an unlawful employment practice for an employer to fail or
refuse to hire, or discharge, any employee, or otherwise to discriminate
against any employee with respect to the compensation, terms,
conditions, or privileges of employment of the employee, because of
genetic information with respect to the employee[.]' 8
" See Daniel Schlein, New Frontiers for Genetic Privacy Law: The Genetic
Information Nondiscrimination Act of 2008, 19 GEO. MASON U. Civ. RTS. L.J.
311, 311 (2008-2009).
12 See id. ("Technological advances in genetic sequencing raise the real
possibility that within the next 10 years the cost of compiling an individual's
complete genome will be driven down to $1,000 or less.").
'3 See generally Dan Vorhaus, MLB Meets GINA, GENOMIcs LAW REP, July
22, 2009, http://www.genomicslawreport.com/index.php/2009/07/22/mlb-meet-
ginal (discussing some of the different reasons MLB uses genetic tests).
14 See Schlein, supra note 11, at 311-12. ("This growing knowledge of
humans' genetic makeup and employers' potential access to it have accentuated
longstanding concerns about discrimination in hiring, firing, or assigning
workers to specific jobs and the likelihood that employers may avoid hiring
those who they believe are likely to create extra costs in the form of sick leave,
resignations, or early retirements.").
15 See Vorhaus, supra note 13.
16 See Genetic Information Nondiscrimination Act of 2008, 42 U.S.C § 201
(2000ff) (2006) (GINA does not include sex within its definition of "genetic
information"' therefore, it is possible that professional sports may test for gender
under GINA.).
7 Id. Introduction.
" Id. § 202(a)(1).
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This Recent Development focuses on professional sports
employers performing genetic tests on players and the problems
these employers will face due to the enactment of GINA. This
Recent Development will also provide possible solutions for these
problems. Part II of this Recent Development addresses the use of
genetic testing in professional sports and the employers' reasons
for using genetic tests on players. Part III explains why the
professional sports industry is distinctive from other forms of
employment. Part IV provides an overview of GINA, including a
brief legislative history and the motivation behind its development.
Part IV also gives an overview of how employers generally use
genetic testing and an explanation of Title 1I, the portion of GINA
that directly addresses employers' responsibilities. Part V
concentrates on why the absence of a "direct threat" exception
within GINA will have a negative impact on professional sports."9
A direct threat exception would allow professional sports
employers to perform genetic tests if there is a concern for the
player's safety. For example, a professional sports employer could
perform a genetic test on a player if a player is believed to have a
genetic heart condition that could prove fatal if the player suffers
from too much physical exertion.
II. USES OF GENETIC TESTING IN SPORTS
Within the past decade, genetic testing has become more
widely available.20 Recently, professional sports employers have
made use of genetic tests to their advantage by performing tests on
players, potential players, and their families.2' The most important
asset to a professional athlete and his or her team is his or her
19 See The Americans with Disabilities Act, 42 U.S.C §§ 12,111(3),
12,113(b), 12,112(b)(6) (1990).
20 Schlein, supra note 11, at 311 (discussing how, as knowledge of genetics
grows so does the availability of genetic testing) "Commercially available
genetic tests are proliferating rapidly and are already available for more than
1,500 diseases in 1,254 clinical laboratories, with an estimated 1,000 more
moving through clinical testing phase." Id.
21 Schmidt & Schwarz, supra note 10, at Al ("[T]he Yankees voided the
signing of an amateur from the Dominican Republic after a DNA test conducted
by Major League Baseball's department of investigations showed that the player
had misrepresented his identity.").
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physical condition, which is why professional sports employers
have been one of the major users of genetic tests within the
employment arena.22
Two highly publicized examples that occurred within the past
five years illustrate why professional sports employers feel the
need to incorporate genetic testing. The first is the story of six-
foot, eleven-inch tall Eddy Curry,23 who played with the Chicago
Bulls beginning in 1998.24 In early 2005, Curry began to feel
chronically ill25 and saw a number of cardiologists to determine if
he had any heart conditions.26 In addition, the Bulls wanted to test
him for a genetic heart condition called hypertrophic
cardiomyopathy ("HCM").27 Curry refused to have the test even
though a similar condition had caused two players to drop dead on
the basketball court.28 The Bulls decided to trade Curry to the New
York Knicks rather than go to court or incur liability for the death
of one of their players.29
The issue of genetic testing has more recently appeared in
professional baseball. Major League Baseball ("MLB") has
admitted to genetically testing some potential players,3 0 especially
in the Dominican Republic.' In 2001, "more than 300 players in
the major and minor leagues were found to have falsified their
22 See generally Andrew E. Rice, Eddy Curry and the Case for Genetic
Privacy in Professional Sports, 6 VA. SPORTS & ENT. L.J. 1 (2006). (discussing
the unique conditions professional sports employers face in terms of the health
of a professional sports employee-player).
23 Id. at 1.
24 Id. at 2.
25 Id. at 2-3.
26 Id
27 Id. at 3-4 ("HCM is a disease of the heart muscle that causes the heart to
enlarge and weaken."); see also Dan Vorhaus, MLB's Genetic Testing Program
at the Plate Again, GENOMICs LAW REP, July 28, 2009, available at
http://www.genomicslawreport.com/index.php/2009/07/28/mlbs-genetic-testing-
program-at-the-plate-again/ (HCM often affects those who are abnormally tall).
28 See Rice, supra note 22, at 3.29 Id. at 2-3.
30 See Schmidt & Schwarz, supra note 10, at Al, A16.
' Tresa Baldas, Baseball's DNA Policy May Be Called Out: New Federal
Law Restricts How Employers Can Use Genetic Information; MLB, Companies
Look For Loophole, FULTON COUNTY DAILY REP., Aug. 3, 2009, at 1.
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birthdates."3 2 Many players claimed to be much younger than they
actually were in order to have a better chance of being recruited by
an MLB team." As a result of identity fraud, professional baseball
employers began to use genetic tests on potential players to
confirm their identities.34 These two examples illustrate two of the
biggest problems that professional sports organizations face-
maintenance of the physical condition of the athletes and
misrepresentation by athletes with regard to their age. Genetic
testing has helped in some way to solve these problems,
particularly in protecting the health of the players.
III. WHY THE PROFESSIONAL SPORTS INDUSTRY IS DISTINCTIVE
FROM OTHER FORMS OF EMPLOYMENT
In terms of employment and labor law, exceptions have been
made for professional sports in certain areas." Professional sports
organizations have argued that in terms of employment law, their
employers and employees confront unique circumstances that are
not common to the typical American employer or employee."
There is claim of a distinction for professional sports concerning
the use of genetic tests. The argument that professional sports
should be distinguished in terms of genetic discrimination
legislation was presented three years prior to the enactment of
GINA." The argument addressed New York State's genetic
discrimination law:
32 Schmidt & Schwarz, supra note 10, at A16.
33 Id.
34 See id. (Fraud was costing MLB a great deal of money, because "[i]n the
eyes of baseball, there's a huge difference between 16 and 19 years old."); see
also Posting of Nathaniel Grow to SPORTS LAW BLOG, MLB Confirms Use of
Genetic Testing on Latin American Prospects, July 23, 2009, http://sports-
law.blogspot.com/search?q=Genetic+Information+Nondiscrimination+Act (In
February 2009, a 19 year old prodigy who was "signed by [the Washington
Nationals] for $1.4 million-was in reality 23-year-old Carlos David Alvarez
Lugo.") (on file with the North Carolina Journal of Law & Technology).
3 See generally Robert D. Manfred Jr., Labor Law and the Sports Industry, 17
HOFSTRA LAB. & EMP. L.J. 133, 132-38 (1999) (discussing certain differences
between labor law and professional sports).
36 See generally id.
37 Rice, supra note 22, at 16.
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A specialized model to deal with genetic information might be
appropriate in the professional sports context for several reasons. First,
the employees are engaged in uniquely physical activities, and
employers rely on employees to be in peak physical condition. Second,
there are substantial amounts of money at stake, for both employees
and employers. Third, the parties already largely govern themselves
through collective bargaining, and a centralized Commissioner's office
can exert pressure on the several employers in the league.38
Also, unlike most other businesses, professional sports
organizations earn a large share of its profits from super-star
athletes. If an athlete dies, the image of the entire organization is
tarnished and can result in a loss of profits. Therefore,
professional sports organizations have a strong moral and financial
interest in protecting their images.
IV. THE GENETIC INFORMATION NONDISCRIMINATION ACT OF
2008'9
A. History of GINA
Representative Louise Slaughter (Democrat-New York)
originally presented a bill to prohibit genetic discrimination to
Congress in 1995.40 However, it took thirteen years before it
became law.4' The spark that ignited the idea for this bill most
likely came from The Human Genome Project.4 2 The goal of the
Human Genome Project was to "identify all the approximately
20,000-25,000 genes in human DNA [and] determine the
sequences of the 3 billion chemical base pairs that make up human
38 Rice, supra note 22, at 47.
39 Schlein, supra note 11, at 318. Prior to the enactment of GINA, "[t]he
accessibility, use, and disclosure of genetic information [were] governed by a
variety of federal, state, and in some cases, local statutes and regulations." Id.
40 Lauren Elizabeth Nuffort, The Genetic Information Nondiscrimination Act
of 2008: Raising A Shield to Genetic Discrimination in Employment and Health
Insurance, 21 HEALTH LAWYER 1, 9 (2009).
41 Id. at 3 (discussing the history of GINA in depth).
42 See genomics.energy.gov, Human Genome Project Information, http://
www.ornl.gov/sci/techresources/HumanGenome/home.shtml (last visited Nov.
10, 2008) (providing information on the Human Genome Project). See also
Nuffort, supra note 40, at 3.
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DNA."43 These goals were achieved," and the discoveries
produced aspirations for curing genetic diseases, but also caused
concern over the possible harmful ways in which genetic
information might be used.45
One of the major concerns of the use of genetic tests, which
prompted Representative Slaughter to introduce GINA, was that
employers and health insurers could use the results of these tests to
discriminate against people with the potential for genetic
diseases.46 Part of Representative Slaughter's motivation47 was that
an employer would wrongly discriminate against a person who has
the potential for a genetic disease, which may never manifest. 48
Slaughter's desire to prevent discrimination against people
whose genetic information showed a risk for acquiring certain
genetic diseases partly manifested from the 1970's cases of
discrimination mostly against African-Americans with the
potential of developing sickle cell anemia.49 Slaughter was also
concerned that "[d]espite the fact that these [genetic] tests are
potentially life-saving, many Americans have not taken advantage
of this technology because they fear discrimination by insurance
companies and their employers."so Opponents of the bill, such as
the U.S. Chamber of Commerce and America's Health Insurance
Plans, argued that there was insufficient evidence of genetic
43 Nuffort, supra note 40, at 3.
44 Id. at 4. See also supra note 42 (providing information on genes and
genetic tests).
45 Nuffort, supra note 40, at 4. ("[T]he presence of a specific genetic variation
may indicate that a person is predisposed to disease but it does not guarantee
that the person will manifest the disease").
46 153 CONG. REC. E120 (daily ed. Jan. 16, 2007) (statement of Rep.
Slaughter).
47 Nuffort, supra note 44, and accompanying text.
48 See Norman-Bloodsaw v. Lawrence Berkely Lab., 135 F.3d 1260 (9th Cir.
1998) (claiming under Title VII that genetic tests were being performed only on
African-American employees for sickle-cell disease and only on women
employees for breast cancer).
49 See supra note 46 ("Throughout the 1970s, many African Americans were
denied jobs, educational opportunities, and insurance based on their carrier
status for sickle cell anemia, despite the fact that a carrier lacked the two copes
of a mutation necessary to get sick").
50 See supra note 46.
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discrimination to support the enactment of a new law." However,
Slaughter was able to persuade other members of Congress 2 of the
seriousness of genetic discrimination, and eventually the bill
became law."
B. Employers and Genetic Testing
Before discussing the provisions for employers under Title II, it
is important to understand the methods and types of genetic tests
employers, including professional sports employers, use with
employees. In terms of methods, employers may perform genetic
screening54 or genetic monitoring" on their employees. An
example of genetic screening would be an employer who conducts
a business requiring employees to operate heavy machinery
choosing to give potential hires genetic tests to determine if there
are any serious physical conditions that might interfere with the
required work. Alternatively, genetic monitoring might occur
when an employer who owns a chemical plant where employees
work around dangerous toxins conducts genetic tests on employees
every few months to observe reactions to the toxins.
5I Nuffort, supra note 40, at 4.
52 154 CONG. REc. E771 (daily ed. April 30, 2008) (statement of Joe Baca)
("Individuals should not be penalized because of their genetic make-up; this is
something no one has control of."). See also 154 CONG. REC. 784 (daily ed.
April 30, 2008) (statement of Hon. Sheila Jackson-Lee) ("The simple fact is
without protection, people are apprehensive about seeking potentially beneficial
genetic services or participating in much needed clinical research.").
5 See Nuffort, supra note 40, at 3.
54 Schlein, supra note 20, at 314-15 ("Genetic testing in the workplace is
usually conducted to screen or monitor employee health. Genetic screening
occurs when an employer or healthcare provider uses medical examinations that
are intended in whole or in part to detect genetic abnormalities or anomalies for
diagnostic or therapeutic purposes, or for genetic counseling or education....
[S]creening is thus 'a predictive tool to assess the likelihood that an otherwise
healthy individual might develop an illness in the future.' ").
ss Id. at 15 ("Genetic monitoring ... is the periodic medical examination of
employees to evaluate whether any of their genes have undergone modification
through chromosomal damage or molecular mutation as the result of exposure to
toxic workplace substances .... Genetic monitoring in the workplace 'helps
pinpoint risks for an exposed group as well as for individuals, aids in prioritizing
evaluations of safety and health practices, and facilities detection of previously
unknown hazards.' ").
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The genetic tests employers perform usually fall into two
categories: diagnostic tests and predictive tests." A diagnostic test
establishes whether a person is currently suffering from a genetic
condition." A predictive test reveals the probability that a person
might develop a genetic disease in the future."
C. Title II-Prohibiting Employment Discrimination on the Basis
of Genetic Information
Title II of GINA specifically addresses the use of "genetic
information" within employment." The Act states that:
It shall be an unlawful employment practice for an employer-
(1) to fail or refuse to hire, or to discharge, any employee, or otherwise
to discriminate against any employee with respect to the compensation,
terms, conditions, or privileges of employment of the employee,
because of genetic information with respect to the employee.o
However, there are exceptions.6 ' They include:
[W]here an employer inadvertently requests or requires family medical
history of the employee or family member of the employee ... health
or genetic services are offered by the employer, including such services
offered as part of a wellness program . . . where an employer requests
or requires family medical history from the employee to comply with
the certification provisions of [the Family and Medical Leave Act] ...
where the information involved is to be used for genetic monitoring of
the biological effects of toxic substances in the workplace . . . the
employee provides prior, knowing, voluntary, and written
authorization.62
56 See Nuffort, supra note 40, at 5 ("Diagnostic tests are used to identify the
presence or absence of a disease. Predictive genetic tests come in two forms:
predictive-presymptomatic and predictive-predispositional. Predictive-
presymptomatic genetic tests are used to predict if an individual will definitely
get a disease in the future, while predictive-predispositional tests are used to
predict the risk of an individual getting a disease in the future.").
5 Id.
58 Id.
59 See 42 U.S.C § 2000ff (2) (2006). Title I addresses genetic discrimination
and health insurance.
60 Id. § 2000ff-l(a)(1).
61 Id. § 2000ff-l(b)(l)-(6) (listing exceptions in detail).
62 Id. See also Nuffort, supra note 40, at 15 (noting that an employer making a
general request for medical history and receiving the genetic information
through that medical history is considered an exception under GINA); Peter
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Title II also contains a confidentiality provision that places a
"limitation on disclosure" on any genetic information that the
employer may have concerning an employee." Unfortunately for
professional sports organizations, it is not clear whether or not
their usage of genetic tests falls under any of the exceptions
provided for employers under GINA.
V. WHY GINA WILL HAVE A NEGATIVE IMPACT ON
PROFESSIONAL SPORTS EMPLOYERS
A. The ADA's" Direct Threat Exception'" and GINA
GINA's major flaw, especially concerning professional sports
employers, is that the exceptions permitted do not tolerate testing
in situations where there is a possible "direct threat"66 to the
Conrad, Wellness in the Work Place: Potentials and Pitfalls of Work-site Health
Promotion, 65 MILBANK Q., 255, 255 (1987) (providing extensive information
on wellness programs). The article defines wellness programs as workplace
programs that "consist of health education, screening, and/or intervention
designed to change employees' behavior in order to achieve better health and
reduce the associated health risks. These programs range from single
intervention (such as hypertension screening) to comprehensive health and
fitness programs." Id. See also 29 U.S.C. 2613 § 103 (1993) ("An employer
may require that a request for leave . . . be supported by a certification issued by
the health care provider. . . ."). The Family Medical Leave Act ("FMLA") is a
law that "entitle[s] employees to take reasonable leave for medical reasons, for
the birth or adoption of the child, and for the care or a child, spouse, or parent
who has a serious health condition." Id.
63 42 U.S.C at § 2000ff-5(b).
6 See Mark A. Rothstein, GINA, the ADA, and Genetic Discrimination in
Employment, 36 J.L. MED & ETHICS 837 (2008) (discussing the relationship
between disability discrimination and genetic discrimination).
65 42 U.S.C. § 12111(3) (1990); see 42 U.S.C. § 12112(b)(6).
66 See Schlein, supra note 20, at 366 ("Unlike the ADA, for example, GINA
does not incorporate any 'direct threat' defense that would enable an employer
to terminate or reassign an employee with a known predisposition or medical
condition that might make him harmful to himself, co-worker, or members of
the public."). See also Rice, supra note 22, at 21-23 (discussing why there
should be a "direct threat" exception in the genetic testing law in the state of
New York).
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employee/player, which is allowed in the Americans with
Disability Act ("ADA"):7
Under the ADA, employers may require "that an individual shall not
pose a direct threat to the health or safety of the individual." An
employer might argue, therefore, that despite having acted on his
mistaken belief that a plaintiff has an impairment that substantially
limits major life activity, the employer has not violated the ADA
because the plaintiffs genetic condition still poses a direct threat to his
health or safety. 8
A "direct threat" exception should be allowed under GINA. The
closest provision to the "direct threat" exception under GINA is the
exception allowing for genetic monitoring in toxic work
environments.69 However, there are no explicit exceptions for an
employer faced with a situation similar to that of the Chicago Bulls
and Eddy Curry. Under a direct threat exception, the Chicago
Bulls would be allowed to test Curry since the HCM, which is
exacerbated by physical activity, would be considered a direct
threat to Curry's physical well being that is significantly increased
by his job duties.70 The Chicago Bulls and an employer screening
an employee for exposure to toxins are both using genetic tests to
protect their employees from a possible workplace hazard. As
with the ADA, if the condition, which can be detected by genetic
tests, could cause an employee to die while performing in the
"course of their employment," the employer should have the
opportunity to request that test, not just for the protection of the
employees' health, but also due to other practical considerations
67 See Rothstein, supra note 71, at 838 ("The ADA is the principal federal law
prohibiting discrimination, including employment discrimination, on the basis of
disability. The ADA, however, does not prohibit all discrimination in
employment based on disability because the ADA's definition of 'an individual
with a disability' is limited. The ADA uses a three-pronged definition of
disability as being a physical or mental impairment that substantially limits one
or more of the major life activities of an individual, a record of such an
impairment, or being regarded as having such an impairment.") (emphasis in
original).
Rice, supra note 22, at 22-23.
6942 U.S.C § 2000ff-l(b)(5).
70 Rice, supra note 22, at 23.
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such as insurance costs and tort claims.' An excellent example
that demonstrates this point is the Supreme Court's decision in
Chevron v. Echazabal.7 2
The Supreme Court's holding in favor of Chevron addressed
why it would benefit employers, not just employees, to do testing
where there was a direct threat to an employee's own health,
"Moral concerns aside, [Chevron] wishes to avoid time lost to
sickness: excessive turnover from medical retirement or death,
litigation under state tort law, and the risk of violating
Occupational Safety and Health Act of 1970."" The Court held
"[a] regulation of the Equal Employment Opportunity Commission
authorizes refusal to hire an individual because his performance on
the job would endanger his own health, owing to a disability. The
question in this case is whether the Americans with Disability Act
... permits the regulation. We hold that it does."74
Using a scenario similar to the facts in Echazabal, if a
professional baseball team finds that a player may be showing
symptoms of HCM and that running to bases may cause sudden
death, then a professional sports team's interests are the same as
Chevron's interests regarding "moral reasons" and other legitimate
concerns such as the cost of losing a valuable player and workers
compensation." The exceptions provided in GINA exclude
situations where employers might want to perform genetic tests for
" 42 U.S.C.A. § 12182(b)(3) (defining a "direct threat" as "a significant risk
to the health or safety of others that cannot be eliminated by a modification of
policies, practices, or procedures or by the provision of auxiliary aids or
services"); see also 42 U.S.C. §§ 12112(b)(6), 12113(b).
72 U.S. 73 (2002). In Echazabal, the respondent was employed by an
independent contractor hired to perform work for Chevron. Echazabal desired to
be employed directly by Chevron, but a medical exam showed that there was a
possible problem with his liver. Chevron refused to hire Echazabal because
doctors said that his liver condition "would be aggravated by continued
exposure to toxins at Chevron's refinery," and as a result Echazabal brought an
action against Chevron. Chevron asserted the defense that Echazabal's
condition was a direct threat to his health, and Echazabal claimed that the direct
threat defense could only be used in cases where there was a threat to others.
73 Id. at 84.
74 Id. at 76.
7 1 d. at 84.
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practical and ethical reasons that are not discriminatory. One
attorney critical of GINA wrote that "[t]here is clearly a good
practical reason for the testing in both cases . . . but neither testing
to confirm identity (or otherwise prevent fraud, as in the case of
MLB) or to prevent even potentially fatal medical conditions (as in
the case of Eddy Curry) is explicitly permitted under GINA." 6
It is not apparent that a direct threat exception provides an
opportunity for professional sports to abuse the privilege to
perform genetic tests. The direct threat exception is not an easy
escape for employers who do not want to hire a person with a
disability. "[T]he standard of proof for an ADA claim under the
'regarded as' prong is significant and requires a showing that an
employer regards the employee as substantially limited in his or
her ability to work by finding the employee's impairment to
'foreclose generally the type of employment involved.' "
The reason why there are so few exceptions under GINA is not
evident. Since professional sports employers began using genetic
tests on employees, there have been few claims of employment
discrimination brought against employers because of these genetic
tests." However, despite the fact that there has been very little
history of actual genetic discrimination, GINA reflects a greater
societal fear of what employers could potentially do with the
genetic information, and not what has actually occurred.7 9
76 Dan Vorhaus, MLB's Genetic Testing Program at the Plate Again,
GENOMICS LAW REPORT, July 28, 2009, http://www.genomicslawreport.com
/index.php/2009/07/28/mlbs-genetic-testing-program-at-the-plate-again/ (last
visited Dec. 3, 2009) (on file with North Carolina Journal of Law &
Technology).
n Schlein, supra note 20, at 321 (explaining how an employer must show that
an employee's ability significantly impairs their ability to perform the job at
hand).
78 Id. at 315 ("Although there have so far been relatively few confirmed cases
of insurance or employment discrimination based on a person's genes, surveys
and media reports consistently suggest that the public remains very wary of the
possible misuse of their medical data.").
7 Id. at 315-16 ("A . . . 1999 survey of cancer genetics specialists disclosed
that 68% of respondents would not inform their insurers if their own tests
revealed a specific variant of colorectal, breast, or ovarian cancer, while 26%
said they would use an alias when being tested."). This survey is an example of
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To subdue fears concerning genetic discrimination, GINA's
structure could be modeled after the ADA in other areas. Once the
offer has been made to the potential employee, the ADA allows
and employer to tell the employee that the offer is conditioned on
the employee's submission to a complete medical examination as
long as the employer provides this same condition to every
potential employee." A provision in GINA that allows genetic
screening if performed on all potential hires would dispel the
notion of discrimination while protecting professional sports
organizations and players.
B. Protection for Employee-Players
A strong argument for genetic testing in professional sports is
that testing does not automatically lead to termination or being
traded to a new professional sports team, but could expose the
player to different forms of treatment that could further the career
or even the life of the player. For example, when basketball player
Reggie Lewis"' dropped dead on the court because he suffered
from HCM, one could speculate that if genetic tests were
performed in advance they could have saved Lewis' life. The
effect of his death on the public and his team members was
described by one sports writer who stated: "[i]f you were at the
playoff game during which [Reggie] Lewis collapsed and in
Boston after he died, you know the scope of the tragedy, which left
his team shattered and his family dealing with unanswered
questions."82 It is unknown why a genetic test was not performed
on Lewis. If genetic testing is allowed in professional sports, other
players may not have to suffer the same fate as Lewis.
how people's fear of the use of this information prevents them from giving it to
the employers in the first place without any proof of how the employers would
use that information.
80 Id. at 322 (explaining the ADA's process of requesting medical exams from
potential employees).
81 See Christine Gorman & Sam Allis, Did Reggie Lewis Have to Die?, TIME,
Aug. 9, 1993, at 43 (detailing the circumstances surrounding the death of Reggie
Lewis).
82 Rice, supra note 22, at 33 (quoting David Aldridge, In Curry Case, Teams
Have no Right to Seek DNA Tests for Players, PHILA. INQUIRER, Oct. 9, 2005,
Sports).
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A legitimate counter-argument for allowing professional sports
organizations to perform genetic testing is that professional sports
employers may not hire athletes even if there is only a slight
chance of developing some type of genetic condition in the
future." The question arises whether it would be rational, for
example, for the NBA to reject the next Lebron James or for the
MLB to reject the next Derek Jeter because the athlete has a slight
potential for a genetic disease. In the history of genetic testing in
sports, the concern has really been for athletes who were at the
time showing symptoms of already manifested genetic diseases.84
Daniel Schlein points out that "[i]t is doubtful, however, whether
an individual with a chromosomal abnormality that caused no
detectable or immediate alterations in biological processes would
be considered 'substantially limited,' since genes within a
particular population will vary naturally."" Also, with the
knowledge genetic tests provide, professional sports teams could
possibly use preventive medical techniques to protect players from
developing a type of genetic disorder.
Professional sports employers traditionally have not chosen to
test players who are asymptomatic and instead wait until there is a
legitimate concern before testing a player." Discretion used by
professional sports employers can reduce the chance that a
professional sports employer is discriminating based upon the mere
possibility that a player may have a genetic disease."
There are also public policy considerations that may allow
genetic testing to protect players. For example, an 18 year-old
young man who has recently graduated from high school with the
opportunity to play professional sports is offered millions of
" Id. at 23. ("[Flrom a common sense perspective, it seems illogical that an
individual could be directly threatened by a condition that neither presently
constitutes an impairment or substantially limits a major life activity ... [t]ests
for the various genes linked to HCM cannot disclose the level of risk associated
with those genes.").
84 See generally id. (providing multiple examples of genetic testing conflicts
in which a player was showing symptoms of a disorder, and no examples of
testing with no symptoms).
85 Schlein, supra note 11, at 325.
86 See generally Rice, supra note 91.
87 See generally id.
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dollars with the prospect of a large fan base and endorsements may
not take the results of his genetic test as seriously or may want to
deny the results for fear of losing his contract.
Allowing genetic tests may, in some circumstances, protect
players who would risk their health to keep lucrative contracts.
Players may fear that negative test results would limit their appeal
to other professional sports teams, decrease endorsements, or
prevent them from participating in playing a sport that they enjoy.
These fears may overpower the possibility that participating in the
sport with a genetic defect may result in a shorter life span.
VI. CONCLUSION
Considering the story of Lou Gehrig," allowing for exceptions
within GINA for genetic testing in professional sports will
probably not lead to a loss of future great players or a rash of
discrimination within the different sports organizations.
Exceptions within GINA, such as the direct threat exception, may
protect players whose genetic illness could be exacerbated by
physical exertion and cause sudden death like the case of Reggie
Lewis.89 Allowing for provisions in GINA for genetic testing in
professional sports can lead to a safer, economically sound, fairer
professional sports world.
88 Schmidt & Schwarz, supra note 10, at A16.
89 Gorman & Allis, supra note 81.

